Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Musculoskeletal | Rheumatology | Nephrology
Disease Category: Systemic Lupus Erythematosus
Location: United States, TX
Clinical Trial Details
Research Study Summary
Have You Been Diagnosed with Systemic Lupus Erythematosus-SLE? Research Study DV7-SLE-02
Currently, a clinical research study is under way to evaluate the safety and tolerability of an investigational drug for people living with Systemic Lupus Erythematosus (SLE) every day. SLE is the most common type of lupus, which mainly strikes young women of African, Hispanic, and Asian descent.
If you have SLE, you may be eligible to participate in this important clinical research study. You will receive study-related health examinations at no cost. Qualified participants will receive study related medication and care at no cost. Other eligibility criteria will apply and insurance is not required.
Compensation for time and travel up to $1,375.00. This is a phase 1 study requiring multiple injections, blood draws, assessments and visits to the site.
To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.
Patient Inclusion Criteria:
You may qualify to participate if you:
- Are at least 18 years old
- Have a confirmed diagnosis of Systemic Lupus Erythematosus
Patient Exclusion Criteria:
- If you do not have a confirmed diagnosis of Systemic Lupus Erythematosus.
To Learn more
Both Male and Female
Up to $1,375
Date Last Changed:
July 18, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.